Skip to main content
Signal8

Patel Mahesh V.

SEC insider (Form 3/4/5 filer). CIK 0001579872. Chief Executive Officer at Lipocine Inc. (LPCN). 7 reported Form 4/5 transactions since Sep 2024; latest on Apr 6, 2026. Located in SALT LAKE CITY, UT.

Companies Patel Mahesh V. has filed insider reports for

  • Lipocine Inc. (LPCN): Director, Officer, Chief Executive Officer
Patel Mahesh V. profile photo

Patel Mahesh V.

CIK: 0001579872

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lipocine Inc. logo
LPCN

Lipocine Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Apr 6, 2026
    Purchase
    Direct
    25K shares at avg. $2.03$51K
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Apr 2, 2026
    Purchase
    Direct
    25K shares at avg. $2.02$51K
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Jan 2, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    25K shares at avg. $8.00-
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Dec 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    8.6K shares at avg. $4.20-
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Jan 2, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16.4K shares at avg. $4.86-
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Dec 23, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    10.3K shares at avg. $4.80-
  • Lipocine Inc. logo
    LPCN

    Lipocine Inc.

    Dec 23, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    26.7K shares at avg. $4.80-

1-7 of 7